Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects

NCT02189772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD, Predominantly Inattentive Type

Interventions

DRUG: Metadoxine extended release
DRUG: Placebo

Sponsor

Alcobra Ltd.